


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.97%
-0.72%
+3.99%
+1.81%
-0.48%
WGS
GeneDx Holdings
$115.17
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
WGS Price Performance
$151.51 (-23.99%)
$116.91 (-1.49%)
$120.65 (-4.54%)
$79.24 (+45.34%)
WGS has High risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

WGS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
WGS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WGS Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
WGS
GeneDx Holdings
115.17
-3.42%
COHU
Cohu
27.84
+0.18%
AMGN
Amgen
322.24
-1.09%
ASND
Ascendis Pharma A/S
213.02
+2.04%
SNY
Sanofi
47.29
-0.67%
What is WGS current stock price?
What are WGS stock strengths?
What is WGS Risk Level?
What is WGS market cap and volume?
What is WGS current Stock IQ?
Should I buy WGS stock right now?
Is WGS a Strong Buy right now?
What does a 'Strong Buy' rating mean for WGS?
What does a 'Strong Sell' rating mean for WGS?
What factors influence WGS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.97%
-0.72%
+3.99%
+1.81%
-0.48%
WGS
GeneDx Holdings
Current Price
$115.17
WGS Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Recently Viewed
WGS
GeneDx Holdings
115.17
-3.42%
COHU
Cohu
27.84
+0.18%
AMGN
Amgen
322.24
-1.09%
ASND
Ascendis Pharma A/S
213.02
+2.04%
SNY
Sanofi
47.29
-0.67%

WGS Price Performance
$151.51 (-23.99%)
$116.91 (-1.49%)
$120.65 (-4.54%)
$79.24 (+45.34%)
WGS Analysts Opinion
WGS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
WGS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WGS Street Sentiment is extremely bullish and have positive views on the near-term outlook
WGS has High risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

Average key support and resistance price levels
WGS Latest Analysis
GeneDx Holdings Becomes Oversold (WGS). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Mon Jan 12, 2026
GeneDx Names Linda Genen Chief Medical Officer . (RTTNews) - GeneDx Holdings Corp. (WGS) a global leader in rare disease diagnosis Tuesday announced appointment of Linda Genen as Chief Medical Officer.
Tue Jan 6, 2026
What Do Analysts Think About GeneDx Holdings Corp. (WGS)?. GeneDx Holdings Corp. (NASDAQ:WGS) is among the 12 Best Genomics Stocks to Invest In. TheFly reported that on December 22 2025 GeneDx Holdings Corp. (NASDAQ:WGS) lifted its price objective at Canaccord from $160 to $170. Canaccord continued to rate the shares as a Buy. The firm stated that the industrys momentum which started in the [….]
Wed Dec 31, 2025
Noteworthy Tuesday Option Activity: WGS GNRC HD. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in GeneDx Holdings Corp (Symbol: WGS) where a total of 2695 contracts have traded so far representing approximately 269500 underlying shares. That amounts to about 69.3
Tue Dec 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.